Oxaliplit 50 Injection
Marketer
Oncozest
Salt Composition
Oxaliplatin (50mg)
Overview Oxaliplit 50 Injection
Colon and rectal cancer treatment employs Oxaliplat 50 Injection, a medication that inhibits or reduces cancerous cell proliferation. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; improper usage or overdose can lead to severe adverse reactions. While therapeutic benefits may take weeks or months to manifest, discontinue use only under your doctor's instruction. Common side effects include nausea, fatigue, vomiting, and diarrhea. This medication can lower blood cell counts (red and white), increasing infection risk. Serious allergic reactions, indicated by symptoms like mouth sores, rash, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitor blood cell counts, along with heart, liver, and uric acid levels. Prior to treatment, inform your doctor about any pre-existing heart, liver, or kidney conditions, or concurrent medications, particularly those for infections. Interactions with other drugs are possible; therefore, disclose all medications to your healthcare provider. This medication is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; consult your doctor regarding sperm preservation. Post-injection dizziness may impair driving ability; refrain from operating vehicles.
Uses of Oxaliplit 50 Injection
Colorectal cancer
Major Benefits of Oxaliplit 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Oxaliplit 50 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxaliplit 50 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Oxaliplit 50 Injection works:
Oxaliplatin 50 Injection is a chemotherapy agent that disrupts the DNA and RNA of malignant cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between alcohol and Oxaliplatin 50 Injection is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxaliplatin 50 Injection during pregnancy poses a confirmed risk to the fetus. Its use is contraindicated except in potentially life-threatening circumstances where the physician deems the potential benefits outweigh the inherent dangers. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Oxaliplatin 50 Injection is contraindicated during lactation. Evidence indicates potential infant harm from the medication.
DrivingUNSAFE
Driving ability may be impaired by Oxaliplat 50 Injection side effects. Oxaliplatin therapy increases the likelihood of dizziness, nausea, vomiting, and other neurological symptoms impacting gait, potentially affecting driving safety.
KidneyCAUTION
Oxaliplit 50 Injection requires careful administration in individuals with severe renal impairment, potentially necessitating dose modification. Consult your physician for guidance. Data regarding Oxaliplit 50 Injection use in such patients is limited. Dose alteration is not advised for those with mild or moderate kidney disease.
LiverCAUTION
Patients with hepatic impairment should receive Oxaliplatin 50 Injection cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Oxaliplit 50 Injection :
Omit a dose of Oxaliplatin 50 Injection? Seek medical advice immediately.
Facts to Know About Oxaliplit 50 Injection
| Label | Value |
|---|---|
| Chemical Category | Platinum Equivalents |
| Developing Good Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Behavior Class | Platinum-based Anticancer Agents |
3,018 People bought this recently